Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q9UEF7
UPID:
KLOT_HUMAN
Alternative names:
-
Alternative UPACC:
Q9UEF7; Q5VZ95; Q96KV5; Q96KW5; Q9UEI9; Q9Y4F0
Background:
Klotho, identified by its gene symbol Q9UEF7, plays a pivotal role in calcium and phosphorus homeostasis, potentially through its involvement in the regulation of vitamin D synthesis. It exhibits a unique function by facilitating the specific interaction between FGF23 and FGFR1, crucial for mineral metabolism. Additionally, Klotho may possess glycosidase activity towards glucuronylated steroids, despite lacking key active site residues, suggesting a non-enzymatic role in vivo.
Therapeutic significance:
Klotho's association with Tumoral calcinosis, hyperphosphatemic, familial, 3, underscores its therapeutic potential. This rare metabolic disorder, characterized by hyperphosphatemia and calcium deposits, highlights the protein's significance in mineral metabolism disorders. Understanding Klotho's role could pave the way for innovative treatments targeting calcium and phosphorus homeostasis.